SOFTMEDX(00648.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 4.65 million, YoY increase of 38.62%
NewTimeSpace News: August 10, 2026, SOFTMEDX(00648.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 34.08 million, decreased by 4.74% YoY; Net Profit stood at HKD 4.65 million, YoY increase of 38.62%; Profit Attributable to Shareholders stood at HKD 4.65 million, YoY increase of 38.62%; Basic Earnings Per Share (EPS) stood at HK cents 4.4.
In terms of profitability, SOFTMEDX Gross Profit changed from HKD 11.48 million in the same period last year to HKD 9.43 million in the current period, decreased by HKD 2.05 million; gross profit margin changed from 32.1% in the same period last year to 27.68% in the current period, decreased by 4.42 percentage points; net profit changed from HKD 3.35 million in the same period last year to HKD 4.65 million in the current period, increased by HKD 1.3 million; net profit margin changed from 9.37% in the same period last year to 13.64% in the current period, increased by 4.27 percentage points.
In terms of earnings quality, SOFTMEDX Operating Profit changed from HKD 5.16 million in the same period last year to HKD 5.88 million in the current period, increased by HKD 719 thousand; Operating Profit Margin changed from 14.42% in the same period last year to 17.25% in the current period, increased by 2.83 percentage points; Net Cash Flow from Operating Activities changed from cash inflow of HKD 1.68 million in the same period last year to cash inflow of HKD 15.2 million in the current period, increased by HKD 13.53 million; Ratio of Net Cash Flow from Operating Activities to Total Operating Revenue changed from 4.69% in the same period last year to 44.62% in the current period, increased by 39.93 percentage points.
In terms of financial soundness, SOFTMEDX Debt-to-Asset Ratio changed from 86.9% in the same period last year to 39.93% in the current period, decreased by 46.97 percentage points; Total Equity changed from HKD 5.809 million in the same period last year to HKD 32.217 million in the current period, increased by HKD 26.41 million; Cash and Cash Equivalents changed from HKD 9.923 million in the same period last year to HKD 26.509 million in the current period, increased by HKD 16.59 million; Current Liabilities changed from HKD 38.18 million in the same period last year to HKD 20.93 million in the current period, decreased by HKD 17.24 million; Quick Ratio changed from 0.92 in the same period last year to 2.4 in the current period, increased by 1.48 percentage points.
By the close of trading on August 10, 2026, SOFTMEDX(00648) saw a gain of 2.61% in its share price, closing at HKD 0.59. The full-day turnover stood at HKD 1.05 million, with the latest market capitalization at HKD 63.2 million.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
